Hyperimmunoglobulin D syndrome: Clinical manifestations and diagnosis
- Yoram C Padeh, MD
Yoram C Padeh, MD
- Instructor in Clinical Medicine
- Mount Sinai Medical Center
- Arye Rubinstein, MD
Arye Rubinstein, MD
- Professor of Pediatrics Microbiology and Immunology
- Albert Einstein College of Medicine and Montefiore Hospital Medical Center
- Section Editors
- Jordan S Orange, MD, PhD
Jordan S Orange, MD, PhD
- Section Editor — Immunology and Immunodeficiency
- Professor of Pediatrics
- Chief of Immunology, Allergy, and Rheumatology
- Baylor College of Medicine
- Texas Children's Hospital
- Robert Sundel, MD
Robert Sundel, MD
- Section Editor — Pediatric Rheumatology
- Associate Professor of Pediatrics
- Harvard Medical School
Hyperimmunoglobulin D syndrome (HIDS, MIM #260920) is a rare, autosomal recessive genetic disorder characterized by recurrent febrile episodes typically associated with lymphadenopathy, abdominal pain, and an elevated serum polyclonal immunoglobulin D (IgD) level. Classic HIDS is due to compound heterozygous or homozygous mutation in the mevalonate kinase (MVK) gene. The underlying genetic defect is not known in variant HIDS.
Recurrent fever that is not due to infection is a clinical feature of several disorders that are collectively referred to as autoinflammatory diseases. HIDS is one of the major periodic fever syndromes, which is a subset of autoinflammatory diseases. An overview of periodic and recurrent fevers and other autoinflammatory diseases is presented separately. (See "Periodic fever syndromes and other autoinflammatory diseases: An overview".)
The clinical manifestations, laboratory features, and diagnosis of HIDS are reviewed here. Pathophysiology and management of HIDS are presented separately. (See "Hyperimmunoglobulin D syndrome: Pathophysiology" and "Hyperimmunoglobulin D syndrome: Management".)
HIDS typically presents during the first year of life . The median age of onset of symptoms was six months in one series (range one week to 10 years of age) . Most patients experienced their first attack within the first year of life (78.1 percent).
HIDS is equally common in males and females. More than 60 percent of patients are of Dutch or French ancestry, although HIDS cases have been reported around the world, including in the United Kingdom, Germany, Italy, Turkey, the Czech Republic, the United States, Japan, and the Arabian peninsula [1,3-6]. An internet-based registry has been created to catalog and follow known patients with HIDS.To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Drenth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 1994; 73:133.
- van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 2008; 87:301.
- van der Meer JW, Vossen JM, Radl J, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1984; 1:1087.
- Simon A, Mariman EC, van der Meer JW, Drenth JP. A founder effect in the hyperimmunoglobulinemia D and periodic fever syndrome. Am J Med 2003; 114:148.
- Hammoudeh M. Hyperimmunoglobulinemia D syndrome in an Arab child. Clin Rheumatol 2005; 24:92.
- D'Osualdo A, Picco P, Caroli F, et al. MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever. Eur J Hum Genet 2005; 13:314.
- Loeliger AE, Kruize AA, Bijilsma JW, et al. Arthritis in hyperimmunoglobulinaemia D. Ann Rheum Dis 1993; 52:81.
- Drenth JP, Boom BW, Toonstra J, Van der Meer JW. Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. Arch Dermatol 1994; 130:59.
- Simon A, Cuisset L, Vincent MF, et al. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med 2001; 135:338.
- Ostuni P, Vertolli U, Marson P. Atypical hypergammaglobulinaemia D syndrome with amyloidosis: an overlap with familial Mediterranean fever? Clin Rheumatol 1996; 15:610.
- Armbrust S, Drenth JP, Schröder C, et al. Tendonitis in variant hyperimmunoglobulinaemia D and periodic fever syndrome--a rare disease with a new symptom. Eur J Pediatr 2005; 164:391.
- Obici L, Manno C, Muda AO, et al. First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum 2004; 50:2966.
- van der Hilst JC, Simon A, Drenth JP. Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 2005; 5:87.
- Lachmann HJ, Goodman HJ, Andrews PA, et al. AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases. Arthritis Rheum 2006; 54:2010.
- Siewert R, Ferber J, Horstmann RD, et al. Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis 2006; 48:e41.
- Kraus CL, Culican SM. Nummular keratopathy in a patient with Hyper-IgD Syndrome. Pediatr Rheumatol Online J 2009; 7:14.
- de Hullu JA, Drenth JP, Struyk AP, van der Meer JW. Hyper-IgD syndrome and pregnancy. Eur J Obstet Gynecol Reprod Biol 1996; 68:223.
- Rubinstein A, personal communication.
- Saulsbury FT, Remmers EF, Aksentijevich I. A novel mutation in TNFRSF1A associated with overlapping features of tumor necrosis factor receptor-associated periodic syndrome and hyper-IgD syndrome. Clin Exp Rheumatol 2010; 28:94.
- Hoffmann F, Lohse P, Stojanov S, et al. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation. Eur J Hum Genet 2005; 13:510.
- Haraldsson A, Weemaes CM, Jónasdóttir S, et al. Serum immunoglobulinD in infants and children. Scand J Immunol 2000; 51:415.
- Stiehm ER, Fudenberg HH. Serum levels of immune globulins in health and disease: a survey. Pediatrics 1966; 37:715.
- Di Rocco M, Caruso U, Waterham HR, et al. Mevalonate kinase deficiency in a child with periodic fever and without hyperimmunoglobulinaemia D. J Inherit Metab Dis 2001; 24:411.
- Saulsbury FT. Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) in a child with normal serum IgD, but increased serum IgA concentration. J Pediatr 2003; 143:127.
- Haraldsson A, Weemaes CM, De Boer AW, et al. Immunological studies in the hyper-immunoglobulin D syndrome. J Clin Immunol 1992; 12:424.
- de Dios García-Díaz J, Alvarez-Blanco MJ. High IgD could be a nonpathogenetic diagnostic marker of the hyper-IgD and periodic fever syndrome. Ann Allergy Asthma Immunol 2001; 86:587.
- Klasen IS, Göertz JH, van de Wiel GA, et al. Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immunol 2001; 8:58.
- Simon A, Bijzet J, Voorbij HA, et al. Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response. J Intern Med 2004; 256:247.
- van der Hilst JC, Drenth JP, Bodar EJ, et al. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid 2005; 12:115.
- Houten SM, Kuis W, Duran M, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 1999; 22:175.
- Drenth JP, Cuisset L, Grateau G, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 1999; 22:178.
- Grose C. Periodic fever in children with hyperimmunoglobulinemia D and mevalonate kinase mutations. Pediatr Infect Dis J 2005; 24:573.
- Frenkel J, Willemsen MA, Weemaes CM, et al. Increased urinary leukotriene E(4) during febrile attacks in the hyperimmunoglobulinaemia D and periodic fever syndrome. Arch Dis Child 2001; 85:158.
- Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med 2001; 345:1748.
- Sarrauste de Menthière C, Terrière S, Pugnère D, et al. INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res 2003; 31:282.
- Mandey SH, Schneiders MS, Koster J, Waterham HR. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum Mutat 2006; 27:796.
- Steichen O, van der Hilst J, Simon A, et al. A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever. J Rheumatol 2009; 36:1677.
- Drenth JP, van Der Meer JW. Periodic fevers enter the era of molecular diagnosis. BMJ 2000; 320:1091.
- Hoffmann GF, Charpentier C, Mayatepek E, et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 1993; 91:915.
- Simon A, Kremer HP, Wevers RA, et al. Mevalonate kinase deficiency: Evidence for a phenotypic continuum. Neurology 2004; 62:994.
- Houten SM, van Woerden CS, Wijburg FA, et al. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet 2003; 11:196.
- Chu X, Li D. Cloning, expression, and purification of His-tagged rat mevalonate kinase. Protein Expr Purif 2003; 27:165.
- Tsimaratos M, Kone-Paut I, Divry P, et al. Mevalonic aciduria and hyper-IgD syndrome: two sides of the same coin? J Inherit Metab Dis 2001; 24:413.
- Stojanov S, Lohse P, Lohse P, et al. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum 2004; 50:1951.
- Gibson KM, Hoffmann GF, Sweetman L, Buckingham B. Mevalonate kinase deficiency in a dizygotic twin with mild mevalonic aciduria. J Inherit Metab Dis 1997; 20:391.
- Prietsch V, Mayatepek E, Krastel H, et al. Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics 2003; 111:258.
- Poll-The BT, Frenkel J, Houten SM, et al. Mevalonic aciduria in 12 unrelated patients with hyperimmunoglobulinaemia D and periodic fever syndrome. J Inherit Metab Dis 2000; 23:363.
- CLINICAL MANIFESTATIONS
- Abdominal pain
- Mucocutaneous manifestations
- Other manifestations
- HIDS during pregnancy
- Variant HIDS
- Overlap syndromes
- LABORATORY FINDINGS
- Immunoglobulin D level
- Immunoglobulin A level
- Acute phase reactants
- Urinary mevalonic acid
- Urinary LTE4
- Genetic testing
- DIFFERENTIAL DIAGNOSIS
- Causes of recurrent or periodic fever
- - Familial Mediterranean fever (FMF)
- - Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)
- - Periodic fevers with aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome
- - Muckle-wells syndrome
- - Familial cold autoinflammatory syndrome (FCAS)
- - Mevalonic aciduria (MEVA)
- Causes of recurrent severe abdominal pain
- - Hereditary or acquired angioedema
- - Acute intermittent porphyria
- Causes of elevated immunoglobulin D
- SUMMARY AND RECOMMENDATIONS